Thomas Stauch/LinkedIn
Jun 13, 2026, 18:21
Thomas Stauch: Discussing the Future of ITP Research and Patient Care
Thomas Stauch, Owner of Hematology and Oncology Practice, Jena, shared a post on LinkedIn:
“One of the best things about EHA is that the conversations often continue beyond the conference itself.
After David Kuter’s excellent presentation on ITP, I had the pleasure of discussing the future of ITP research and patient care with him on the train ride home.
Thank you for the inspiring exchange and valuable insights.”
Stay updated with Hemostasis Today.
-
Sep 11, 2026, 15:37Empowering Local Stakeholders to Advance Hemophilia Care in Côte d’Ivoire – World Federation of Hemophilia
-
Sep 11, 2026, 15:34Dhargam Aljebouri: A New Milestone for Transfusion Education in Iraq
-
Sep 11, 2026, 15:17Shadi Tabibian: Where Laboratory Precision Meets Clinical Care
-
Sep 11, 2026, 14:58Kevin Land: Connecting Donors to Patients Across the Spectrum of Care
-
Sep 11, 2026, 14:45Jorge Mascaro: The Growing Impact of the UK Aortic Society on Aortic Disease Care
-
Sep 11, 2026, 14:31Hany Ibrahim: Lp(a) Lowering Meets a Critical Test in the Lp(a)HORIZON Trial
-
Sep 11, 2026, 13:35How Non-Factor Therapies Are Changing Hemophilia Care – Seminars in Thrombosis and Hemostasis
-
Sep 11, 2026, 13:21Emmanuel J Favaloro: Rethinking Quality Control in VWD Testing
-
Sep 11, 2026, 13:10Tessa Youngner: New Free E-Course Introduces Comprehensive SCD Care